KEYCORP /NEW/ Debt Disclosure
| December 31, | ||||||||
| Dollars in millions | 2025 | 2024 | ||||||
| Federal funds purchased | $ | — | $ | — | ||||
| Securities sold under repurchase agreements | 13 | 14 | ||||||
| Other short-term borrowings | 1,071 | 2,130 | ||||||
| December 31, | Stated Rate | Maturity | Carrying Value | |||||||||||
| Dollars in millions | 2025 | 2025 | 2025 | 2024 | ||||||||||
| Parent Company | ||||||||||||||
| Senior notes | 2.25% - 6.40% | 2027 - 2035 | $ | 4,659 | $ | 4,251 | ||||||||
| Junior subordinated debentures | 4.99% - 7.75% | 2028 - 2037 | 447 | 444 | ||||||||||
| Other variable rate notes | — | 599 | ||||||||||||
| Total parent company | $ | 5,106 | $ | 5,294 | ||||||||||
| Subsidiaries | ||||||||||||||
| Senior notes | 3.97% - 5.85% | 2027 - 2039 | $ | 2,229 | $ | 4,540 | ||||||||
| Subordinated notes | 3.40% - 6.95% | 2026 - 2032 | 1,932 | 1,869 | ||||||||||
| Federal Home Loan Bank advances | 1.39% - 7.36% | 2026 - 2042 | 560 | 79 | ||||||||||
Other long-term debt(a) | 90 | 112 | ||||||||||||
| Revolving loans | — | 211 | ||||||||||||
| Total subsidiaries | $ | 4,811 | $ | 6,811 | ||||||||||
| Total long-term debt | $ | 9,917 | $ | 12,105 | ||||||||||
| Dollars in millions | Parent | Subsidiaries | Total | ||||||||
| 2026 | $ | — | $ | 1,111 | $ | 1,111 | |||||
| 2027 | 771 | 1,275 | 2,046 | ||||||||
| 2028 | 903 | 307 | 1,210 | ||||||||
| 2029 | 881 | 345 | 1,226 | ||||||||
| 2030 | — | 15 | 15 | ||||||||
| All subsequent years | 2,551 | 1,758 | 4,309 | ||||||||
Historical Timeline
| Fiscal Year | Filed | |
|---|---|---|
| 2025 | Feb 23, 2026 | Showing above |
| 2024 | Feb 21, 2025 | |
| 2023 | Feb 22, 2024 | |
| 2022 | Feb 22, 2023 | |
| 2021 | Feb 22, 2022 | |
| 2020 | Feb 22, 2021 | |
| 2019 | Feb 26, 2020 | |
| 2018 | Feb 25, 2019 | |
| 2017 | Feb 26, 2018 | |
| 2016 | Feb 28, 2017 | |
| 2015 | Feb 24, 2016 | |
About Debt Disclosures
Debt disclosures detail a company's borrowing structure — the types of instruments, interest rates, maturity schedule, and covenant restrictions that define its financial obligations and flexibility. This section is essential for assessing refinancing risk, interest rate exposure, and the margin of safety against financial distress.
Key signals: the maturity schedule reveals concentration risk — large maturities within 1-2 years during tight credit markets can force dilutive refinancing or asset sales. Compare the fair value of debt against carrying amount to gauge whether the market views the company's credit risk differently than the balance sheet suggests. Watch covenant compliance disclosures for tightening cushions, especially leverage and interest coverage ratios. Variable-rate debt exposure quantifies sensitivity to interest rate changes. Secured versus unsecured mix affects recovery rates and future borrowing capacity. Compare net debt-to-EBITDA against industry peers and covenant limits to assess financial health.